Cambridge Acquisition's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Cambridge Acquisition (CAQ) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
API endpoints for this dataset
Cambridge Acquisition's Competitor Quality Breadth
Group definitions: see Methodology: Performance Group Definitions.
| Entity | Profitable | Expanding | Above Industry Growth | Distressed |
|---|---|---|---|---|
| Cambridge Acquisition Corp | - | - | - | Yes |
| High-Confidence Competitors (1) | - | - | - | |
| Similar-Size Competitors (10) | - | - | - |
Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.
CAQ Stock Performance relative to its Competitors
CAQ Stock Performance relative to High-Confidence Competitors
CAQ Stock Performance relative to Similar-Size Competitors
Cambridge Acquisition's Comment on Competition and Industry Peers
Cambridge Acquisition's Competitors Named by the Company
Competitive relationships identified from Cambridge Acquisition reports and corroborating sources, each with a basis and confidence.| Competitor | Basis | Confidence |
|---|---|---|
| MindMed | Company report | 85% |
| JUUL | Company report | 85% |
| Beckley Psytech | Company report | 85% |
| Mindbloom | Company report | 85% |
| Compass Pathways | Company report | 85% |
Company report basis, confidence, active dates and source counts for Cambridge Acquisition's named competitors require a Commercial License.
Methodology: see Methodology: Peer & Competitor Identification, Sourcing.
